Endymed Ltd
Share · IL0011010217 (XTAE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Endymed Ltd
No Price
Company Profile for Endymed Ltd Share
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey.
Company Data
Name Endymed Ltd
Company Endymed Ltd
Website
https://www.endymed.com
Primary Exchange 
TASE
TASE
ISIN IL0011010217
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Yossi Bar-On CPA
Market Capitalization 44 Mio
Country United States of America
Currency ILA
Employees 0,0 T
Address 4400 Route 9 South, 07728 Freehold
IPO Date 2007-07-19
Stock Splits
| Date | Split |
|---|---|
| 28.01.2018 | 1:20 |
Ticker Symbols
| Name | Symbol |
|---|---|
| TASE | ENDY.TA |
More Shares
Investors who hold Endymed Ltd also have the following shares in their portfolio:
